This is a non-core endpoint: only basic statistics are computed.
Excessive and redundant skin and subcutaneous tissue
L12_EXCESSSKINDANDSUBCUTIS
No definition available.
Endpoint definition
↥429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
14
Check minimum number of events None
14
Include endpoints None
14
Remove individuals based on genotype QC
14
Control definitions
Extra metadata
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to Excessive and redundant skin and subcutaneous tissue based on the number of shared cases.
Broader endpoints:
- Other disorders of skin and subcutaneous tissue, not elsewhere classified
- Other disorders of skin and subcutaneous tissue
- Diseases of the skin and subcutaneous tissue
- Injury, poisoning and certain other consequences of external causes
- Anti-inflammatory and antirheumatic products, non-steroids
Narrower endpoints:
None
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 14 | 14 | - |
Unadjusted prevalence (%) | 0.00 | 0.01 | - |
Mean age at first event (years) | 51.71 | 51.71 | - |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: L12_EXCESSSKINDANDSUBCUTIS – Excessive and redundant skin and subcutaneous tissue
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Excessive and redundant skin and subcutaneous tissue
↥Endpoint not on priority list, no data to show.